Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy

NCT05979220 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
178
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shuangyue Liu